Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Franco

Showing results (51-60 of 420) with videos related to

Pageof 42
Sort By:
Expert Opinion on Drug Discovery|July 25, 2012
Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulatorsRafael Franco, Enric I Canela, Vicent Casado, et al.
Cells|August 9, 2024
The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease ProgressionRafael Franco, Claudia Garrigós, Jaume Lillo, et al.
Progress in Brain Research|June 28, 2014
Dopamine receptor heteromeric complexes and their emerging functionsSusan R George, Andras Kern, Roy G Smith, et al.
Frontiers in Pharmacology|April 12, 2016
Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor HeteromerizationRafael Franco, Eva Martínez-Pinilla, José L Lanciego, et al.
Frontiers in Pharmacology|February 15, 2021
The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein InteractionsRafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, et al.
Neurobiology of Aging|July 6, 2012
CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patientsMaite Solas, Paul T Francis, Rafael Franco, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic NeuronsRafael Franco, Joan Serrano-Marín, Gemma Navarro, et al.
Cells|November 27, 2021
Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and ImmunotherapyRafael Franco, Rafael Rivas-Santisteban, Gemma Navarro, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|December 18, 2007
Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerizationJorge Gandía, Carme Lluís, Sergi Ferré, et al.
Neuropharmacology|July 28, 2015
Purinergic signaling in Parkinson's disease. Relevance for treatmentGemma Navarro, Dasiel O Borroto-Escuela, Kjell Fuxe, et al.
Pageof 42

Showing results (51-60 of 420) with videos related to

Sort By:
Pageof 42
Expert Opinion on Drug Discovery|July 25, 2012
Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulatorsRafael Franco, Enric I Canela, Vicent Casado, et al.
Cells|August 9, 2024
The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease ProgressionRafael Franco, Claudia Garrigós, Jaume Lillo, et al.
Progress in Brain Research|June 28, 2014
Dopamine receptor heteromeric complexes and their emerging functionsSusan R George, Andras Kern, Roy G Smith, et al.
Frontiers in Pharmacology|April 12, 2016
Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor HeteromerizationRafael Franco, Eva Martínez-Pinilla, José L Lanciego, et al.
Frontiers in Pharmacology|February 15, 2021
The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein InteractionsRafael Franco, Rafael Rivas-Santisteban, Irene Reyes-Resina, et al.
Neurobiology of Aging|July 6, 2012
CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patientsMaite Solas, Paul T Francis, Rafael Franco, et al.
Antioxidants (Basel, Switzerland)|October 28, 2023
The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic NeuronsRafael Franco, Joan Serrano-Marín, Gemma Navarro, et al.
Cells|November 27, 2021
Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and ImmunotherapyRafael Franco, Rafael Rivas-Santisteban, Gemma Navarro, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|December 18, 2007
Light resonance energy transfer-based methods in the study of G protein-coupled receptor oligomerizationJorge Gandía, Carme Lluís, Sergi Ferré, et al.
Neuropharmacology|July 28, 2015
Purinergic signaling in Parkinson's disease. Relevance for treatmentGemma Navarro, Dasiel O Borroto-Escuela, Kjell Fuxe, et al.
Pageof 42